Replimune Group, Inc. (REPL)
9.245
+0.28
(+3.07%)
USD |
NASDAQ |
Jun 09, 16:00
9.24
0.00 (0.00%)
After-Hours: 20:00
Replimune Group SG&A Expense (Quarterly) : 18.73M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 101.25M |
| Oncolytics Biotech, Inc. | 4.729M |
| Rocket Pharmaceuticals, Inc. | 17.06M |
| Cogent Biosciences, Inc. | 28.24M |
| Lantern Pharma, Inc. | 1.680M |